@article{article, title  = {{Abstract 3413: Dissecting the combination of gemcitabine and the Chk1 inhibitor MK-8776 <i>in vitro</i> and <i>in vivo</i>: cell cycle perturbation and the impact of administration schedule.}},

 publisher = {{American Association for Cancer Research (AACR)}},

 url = {{http://dx.doi.org/10.1158/1538-7445.am2013-3413 }},

 year = {{2013}},

 month = {{4}},

 author = {{Eastman A and Montano R and Thompson R and Khan N and Hou H and Lewis LD and Seigne JD and Ernstoff MS}},

 doi = {{10.1158/1538-7445.am2013-3413}},

 volume = {{73}},

 journal = {{Cancer Research}},

 issue = {{8_Supplement}},

 pages = {{3413-3413}},

 note = {{Accessed on 2024/12/27}}}